PhD Opportunities in Drug Discovery, Neurobiology, and Medicinal Chemistry in Europe (2025–2027) German Cancer Research Center in Germany

Are you interested in pursuing a PhD in drug discovery, neurobiology, or medicinal chemistry in Europe? Multiple leading research institutions are currently accepting applications for their international PhD programs for the 2025–2027 intake. These programs offer world-class training in biomedical research, cancer research, systems neuroscience, and molecular life sciences, with a strong emphasis on interdisciplinary collaboration and innovation.

DKFZ International PhD Program (German Cancer Research Center, Heidelberg, Germany): This fully funded, structured program provides doctoral researchers with tailored mentoring and training in cancer research. PhD students join over 500 peers in 100+ research groups, working on projects ranging from molecular pharmacology to drug discovery. The program covers tuition and provides a stipend, with students enrolled in top German universities. The application deadline for the 2026 intake is December 15, 2025. More info.

EMBL International PhD Programme (Multiple Locations in Europe): EMBL offers interdisciplinary PhD projects in neurobiology, medicinal chemistry, and related fields. The next application window is expected in early 2026. More info.

Life Science Zurich Graduate School (ETH Zurich & University of Zurich): This program features multiple PhD tracks in systems neuroscience and molecular life sciences. The deadline for the 2026 intake is May 2026. More info.

Applicants should have a strong academic background in biology, chemistry, medical science, neuroscience, or related fields, and demonstrate research experience and proficiency in English. These programs are fully funded, offering tuition waivers and stipends, and provide comprehensive career development resources. For more information and to apply, visit the official program websites linked above.